Cancer drugs come with high price tags and uncertain benefits, yet a UK-style cost cap is unlikely to be put in place in the U.S.
Read "Time to Consider Cost in Evaluating Cancer Drugs in US?"
See the archived story and questionnaire in which the reporter writes about how this story was written.